دورية أكاديمية

Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food.

التفاصيل البيبلوغرافية
العنوان: Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food.
المؤلفون: Holt MK; Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology and Pharmacology, University College London, London, U.K., Richards JE; Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology and Pharmacology, University College London, London, U.K., Cook DR; Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology and Pharmacology, University College London, London, U.K., Brierley DI; Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology and Pharmacology, University College London, London, U.K., Williams DL; Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL., Reimann F; Institute of Metabolic Science and MRC Metabolic Diseases Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge, U.K., Gribble FM; Institute of Metabolic Science and MRC Metabolic Diseases Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge, U.K., Trapp S; Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology and Pharmacology, University College London, London, U.K. s.trapp@ucl.ac.uk.
المصدر: Diabetes [Diabetes] 2019 Jan; Vol. 68 (1), pp. 21-33. Date of Electronic Publication: 2018 Oct 02.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE
أسماء مطبوعة: Publication: Alexandria, VA : American Diabetes Association
Original Publication: [New York, American Diabetes Association]
مواضيع طبية MeSH: Brain/*metabolism , Glucagon-Like Peptide 1/*metabolism , Solitary Nucleus/*metabolism, Animals ; Eating/physiology ; Electrophysiology ; Female ; Glucose Tolerance Test ; Immunohistochemistry ; Male ; Mice ; Obesity/metabolism ; Proglucagon/metabolism
مستخلص: Centrally administered glucagon-like peptide 1 (GLP-1) supresses food intake. Here we demonstrate that GLP-1-producing (PPG) neurons in the nucleus tractus solitarii (NTS) are the predominant source of endogenous GLP-1 within the brain. Selective ablation of NTS PPG neurons by viral expression of diphtheria toxin subunit A substantially reduced active GLP-1 concentrations in brain and spinal cord. Contrary to expectations, this loss of central GLP-1 had no significant effect on the ad libitum feeding of mice, affecting neither daily chow intake nor body weight or glucose tolerance. Only after bigger challenges to homeostasis were PPG neurons necessary for food intake control. PPG-ablated mice increased food intake after a prolonged fast and after a liquid diet preload. Consistent with our ablation data, acute inhibition of hM 4 Di-expressing PPG neurons did not affect ad libitum feeding; however, it increased refeeding intake after fast and blocked stress-induced hypophagia. Additionally, chemogenetic PPG neuron activation through hM 3 Dq caused a strong acute anorectic effect. We conclude that PPG neurons are not involved in primary intake regulation but form part of a secondary satiation/satiety circuit, which is activated by both psychogenic stress and large meals. Given their hypophagic capacity, PPG neurons might be an attractive drug target in obesity treatment.
(© 2018 by the American Diabetes Association.)
التعليقات: Comment in: Diabetes. 2019 Jan;68(1):15-17. (PMID: 30573675)
References: Brain Res. 1998 Jan 1;779(1-2):75-83. (PMID: 9473596)
J Clin Invest. 2011 Jun;121(6):2413-21. (PMID: 21606595)
J Neurosci. 2011 Mar 9;31(10):3904-13. (PMID: 21389245)
Cell Rep. 2015 Aug 4;12(5):726-33. (PMID: 26212334)
J Clin Invest. 2002 Jul;110(1):43-52. (PMID: 12093887)
Mol Metab. 2017 Jun 07;6(8):909-921. (PMID: 28752054)
J Neurosci. 2014 May 7;34(19):6495-509. (PMID: 24806676)
Mol Metab. 2017 Nov;6(11):1350-1359. (PMID: 29107283)
Nat Commun. 2017 May 18;8:15097. (PMID: 28516907)
J Clin Invest. 2014 Jun;124(6):2456-63. (PMID: 24762441)
Nat Commun. 2016 Jun 15;7:11905. (PMID: 27301688)
J Neurosci. 2003 Jul 16;23(15):6163-70. (PMID: 12867498)
Physiol Behav. 2013 Sep 10;121:35-42. (PMID: 23391574)
Neuron. 2017 Nov 15;96(4):897-909.e5. (PMID: 29056294)
Diabetes Obes Metab. 2018 May;20(5):1223-1234. (PMID: 29327400)
Neuroscience. 2015 Jan 22;284:872-87. (PMID: 25450967)
Physiol Rev. 2015 Apr;95(2):513-48. (PMID: 25834231)
Neuroscience. 2013 Jan 15;229:130-43. (PMID: 23069752)
Endocrinology. 2009 Jun;150(6):2654-9. (PMID: 19264875)
Physiol Behav. 2014 Sep;136:47-54. (PMID: 24508750)
Am J Physiol Regul Integr Comp Physiol. 2016 May 15;310(10):R906-16. (PMID: 26936779)
Diabetes. 2011 Nov;60(11):2701-9. (PMID: 21885869)
J Neurosci. 2015 Jul 29;35(30):10701-14. (PMID: 26224855)
Nat Neurosci. 2011 Mar;14(3):297-9. (PMID: 21278730)
Nat Methods. 2012 Jun 28;9(7):676-82. (PMID: 22743772)
J Biol Methods. 2014;1(2):. (PMID: 25606571)
Nat Neurosci. 2017 May;20(5):708-716. (PMID: 28368384)
Cogent Biol. 2016 Dec 31;2(1):1229086. (PMID: 27722184)
Am J Physiol Regul Integr Comp Physiol. 2016 Jul 1;311(1):R115-23. (PMID: 27097661)
J Physiol. 2016 May 15;594(10):2607-28. (PMID: 26931093)
Diabetologia. 2012 Sep;55(9):2445-55. (PMID: 22638549)
J Clin Invest. 2017 Mar 1;127(3):1031-1045. (PMID: 28218622)
Am J Physiol. 1999 Aug;277(2):R582-90. (PMID: 10444567)
Am J Physiol Regul Integr Comp Physiol. 2003 Aug;285(2):R470-8. (PMID: 12714357)
Front Neurosci. 2013 Jan 21;6:199. (PMID: 23346044)
Cell Metab. 2008 Dec;8(6):532-9. (PMID: 19041768)
J Comp Neurol. 1999 Jan 11;403(2):261-80. (PMID: 9886047)
J Neurosci. 2010 Sep 15;30(37):12466-73. (PMID: 20844141)
J Clin Invest. 2011 Apr;121(4):1424-8. (PMID: 21364278)
Physiol Behav. 2017 Jul 1;176:195-206. (PMID: 28095318)
Mol Metab. 2018 May;11:33-46. (PMID: 29650350)
Diabetes. 2010 Aug;59(8):1890-8. (PMID: 20522593)
J Neurosci. 2017 Jan 4;37(1):184-193. (PMID: 28053040)
J Neurosci. 2003 Apr 1;23(7):2939-46. (PMID: 12684481)
Diabetes. 2000 Sep;49(9):1552-60. (PMID: 10969840)
Neuron. 2016 Feb 17;89(4):683-94. (PMID: 26889809)
Neuroscience. 2011 Apr 28;180:111-21. (PMID: 21329743)
Neuroscience. 1997 Mar;77(1):257-70. (PMID: 9044391)
Endocrinology. 2017 Jul 1;158(7):2124-2133. (PMID: 28430981)
Am J Physiol Regul Integr Comp Physiol. 2016 May 15;310(10):R885-95. (PMID: 27030669)
معلومات مُعتمدة: MC_UU_12012/3 United Kingdom MRC_ Medical Research Council; MR/N02589X/1 United Kingdom MRC_ Medical Research Council; FS/14/43/30960 United Kingdom BHF_ British Heart Foundation; MC_UU_00014/5 United Kingdom MRC_ Medical Research Council; MR/J013293/2 United Kingdom MRC_ Medical Research Council; R01 DK095757 United States DK NIDDK NIH HHS; MC_UU_00014/3 United Kingdom MRC_ Medical Research Council
المشرفين على المادة: 55963-74-1 (Proglucagon)
89750-14-1 (Glucagon-Like Peptide 1)
تواريخ الأحداث: Date Created: 20181004 Date Completed: 20190325 Latest Revision: 20210109
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC6314470
DOI: 10.2337/db18-0729
PMID: 30279161
قاعدة البيانات: MEDLINE
الوصف
تدمد:1939-327X
DOI:10.2337/db18-0729